Skip to content

    Oscar Health (OSCR) stock price & financials

    View OSCR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+79.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $2.42B
    $2.39B
    $3.05B
    $2.86B
    $2.99B
    +23.2%
    $2.81B
    +17.3%
    $4.65B
    +52.6%
    $4.88B
    +70.4%
    Strengthening
    Operating Profit
    -$48.37M
    -$147.73M
    $297.12M
    -$230.48M
    -$129.25M
    -167.2%
    -$333.75M
    -125.9%
    $704.09M
    +137.0%
    $388.63M
    Strengthening
    Net Profit
    -$54.60M
    -$153.55M
    $275.27M
    -$228.36M
    -$137.45M
    -151.8%
    -$352.61M
    -129.6%
    $679.00M
    +146.7%
    $361.81M
    Strengthening
    EPS
    $-0.22
    $1.10
    $-0.89
    $-0.53
    -140.9%
    $2.28
    +107.3%
    $1.20
    Strengthening
    Other Income
    $1.88M
    $68.0K
    -$2.92M
    $2.79M
    -$3.18M
    -269.6%
    -$20.03M
    -29557.4%
    $71.0K
    -$915.0K
    -132.7%
    Weakening
    Interest
    $5.82M
    $6.03M
    $5.99M
    $5.85M
    $6.86M
    +17.9%
    -$1.10M
    -118.2%
    $5.38M
    -10.2%
    $4.71M
    -19.5%
    Weakening
    Depreciation
    Profit before Tax
    -$52.31M
    -$153.69M
    $288.21M
    -$233.54M
    -$139.29M
    -166.3%
    -$352.68M
    -129.5%
    $698.77M
    +142.5%
    $383.01M
    Strengthening
    MarginsOPM
    -2.0%
    -6.2%
    9.8%
    -8.1%
    -4.3%
    -116.5%
    -11.9%
    -92.9%
    15.2%
    +55.4%
    8.0%
    Weakening
    Tax
    -4.0%
    0.3%
    4.4%
    2.2%
    1.3%
    0.1%
    -73.1%
    2.8%
    -35.8%
    5.5%
    +156.0%
    Strengthening
    ReturnsROIC
    2.4%
    6.8%
    -12.2%
    10.1%
    6.1%
    +151.8%
    15.6%
    +129.6%
    -30.1%
    -146.7%
    -16.1%
    -258.4%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$336.64M$826.33M$1.10B$1.56B$1.87B$1.53B$2.77B$4.08B
    Short-Term Investments
    Total Current Assets$1.87B$2.31B$4.12B$3.06B$2.85B$4.61B$9.37B
    Net PP&E$35.81M$119.57M$127.89M$124.80M$123.95M$139.89M$101.49M
    Goodwill
    Intangibles
    Total Assets$2.27B$3.32B$4.53B$3.60B$4.84B$6.33B$11.23B
    LiabilitiesTotal Current Liabilities$1.67B$1.85B$3.26B$2.43B$3.46B$4.86B$8.69B
    Short-Term Debt
    Long-Term Debt$142.49M$0$298.00M$298.78M$299.56M$430.10M$431.63M
    Long-Term Leases$76.84M$72.17M$66.80M$60.65M$51.99M
    Total Liabilities$1.82B$1.93B$3.63B$2.80B$3.82B$5.34B$9.17B
    EquityCommon Stock & APIC$2.0K
    Retained Earnings-$1.43B-$2.00B-$2.61B-$2.88B-$2.85B-$3.29B-$2.25B
    Total Equity-$945.14M-$1.30B$1.39B$890.38M$803.97M$1.01B$977.65M$2.05B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$165.37M$222.73M-$181.75M$380.35M-$272.16M$978.19M$1.09B$4.42B
    Cash from Investing$150.51M-$344.71M-$774.51M-$226.52M$577.19M-$1.39B-$241.06M-$3.32B
    Cash from Financing-$2.12M$611.71M$1.24B$301.11M$6.45M$68.39M$399.21M$381.90M
    SummaryCapital Expenditure-$26.00M-$14.02M-$25.89M-$29.01M-$25.58M-$27.90M-$36.37M-$38.63M
    Free Cash Flow-$191.37M$208.71M-$207.63M$351.34M-$297.74M$950.30M$1.06B$4.38B
    FCF Margin-39.2%45.1%-11.3%8.9%-5.1%10.4%9.0%28.6%

    Ratios